276 related articles for article (PubMed ID: 30043636)
1. Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy.
Karatas A; Turkmen E; Erdem E; Dugeroglu H; Kaya Y
Biomark Med; 2018 Sep; 12(9):953-959. PubMed ID: 30043636
[TBL] [Abstract][Full Text] [Related]
2. Relation of Monocyte/High-Density Lipoprotein Cholesterol Ratio with Coronary Artery Disease in Type 2 Diabetes Mellitus.
Ya G; Qiu Z; Tianrong P
Clin Lab; 2018 Jun; 64(6):901-906. PubMed ID: 29945315
[TBL] [Abstract][Full Text] [Related]
3. Investigation of MHR-nephropathy relationship and the effect of SGLT2is on MHR in patients with type 2 diabetes.
Tekin BG; Pektaş E
Ir J Med Sci; 2024 Jun; 193(3):1283-1287. PubMed ID: 38366276
[TBL] [Abstract][Full Text] [Related]
4. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ
J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
[TBL] [Abstract][Full Text] [Related]
5. Association of monocyte-to-high density lipoprotein-cholesterol ratio with peripheral neuropathy in patients with Type II diabetes mellitus.
Gökçay Canpolat A; Emral R; Keskin Ç; Canlar Ş; Şahin M; Çorapçioğlu D
Biomark Med; 2019 Aug; 13(11):907-915. PubMed ID: 31321988
[No Abstract] [Full Text] [Related]
6. Circulating ApoE level is independently associated with urinary albumin excretion in type 2 diabetic patients.
Ling Y; Li X; Gu Q; Gao X
Intern Med; 2011; 50(24):2961-6. PubMed ID: 22185986
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress markers in type 2 diabetes patients with diabetic nephropathy.
Chou ST; Tseng ST
Clin Exp Nephrol; 2017 Apr; 21(2):283-292. PubMed ID: 27233502
[TBL] [Abstract][Full Text] [Related]
8. Association of monocyte-to-high density lipoprotein ratio with arterial stiffness in patients with diabetes.
Mayasari DS; Taufiq N; Hariawan H
BMC Cardiovasc Disord; 2021 Jul; 21(1):362. PubMed ID: 34330221
[TBL] [Abstract][Full Text] [Related]
9. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
10. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
[TBL] [Abstract][Full Text] [Related]
12. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
14. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients.
Żyłka A; Dumnicka P; Kuśnierz-Cabala B; Gala-Błądzińska A; Ceranowicz P; Kucharz J; Ząbek-Adamska A; Maziarz B; Drożdż R; Kuźniewski M
Mediators Inflamm; 2018; 2018():7659243. PubMed ID: 30158836
[TBL] [Abstract][Full Text] [Related]
15. Urinary copper excretion in type 2 diabetic patients with nephropathy.
Ito S; Fujita H; Narita T; Yaginuma T; Kawarada Y; Kawagoe M; Sugiyama T
Nephron; 2001 Aug; 88(4):307-12. PubMed ID: 11474224
[TBL] [Abstract][Full Text] [Related]
16. [Can urine albumin/creatinine ratio replace 24 hours urinary albumin?].
Liu R; Zhu H; Yang JH; Gao ZA; Yuan XX; Li XC; Wang JY; Chang BC
Zhonghua Nei Ke Za Zhi; 2019 May; 58(5):377-381. PubMed ID: 31060147
[No Abstract] [Full Text] [Related]
17. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients.
El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI
IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886
[TBL] [Abstract][Full Text] [Related]
18. The relationship between monocyte to high-density lipoprotein cholesterol ratio and diabetic nephropathy.
Onalan E
Pak J Med Sci; 2019; 35(4):1081-1086. PubMed ID: 31372147
[TBL] [Abstract][Full Text] [Related]
19. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus.
Nie F; Wu D; Du H; Yang X; Yang M; Pang X; Xu Y
J Diabetes Complications; 2017 Mar; 31(3):594-598. PubMed ID: 27916483
[TBL] [Abstract][Full Text] [Related]
20. Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio.
Shao Y; Lv C; Yuan Q; Wang Q
J Diabetes Res; 2016; 2016():1925424. PubMed ID: 27069929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
